about
Budget impact of parenteral iron treatment of iron deficiency: methodological issues raised by using real-life data.Costs of managing severe immune thrombocytopenia in adults: a retrospective analysis."Budget impact analyses": a practical policy making tool for drug reimbursement decisionsDealing with Time in Health Economic Evaluation: Methodological Issues and Recommendations for Practice.Relationship between financial impact and coverage of drugs in Australia.Multicohort models in cost-effectiveness analysis: why aggregating estimates over multiple cohorts can hide useful informationFinding legitimacy for the role of budget impact in drug reimbursement decisions.Cost-effectiveness of new adult pneumococcal vaccination strategies in Italy.Budget-impact analyses: a critical review of published studies.A critical systematic review of budget impact analyses on drugs in the EU countries.A Methodological Review of US Budget-Impact Models for New Drugs.Capturing Budget Impact Considerations Within Economic Evaluations: A Systematic Review of Economic Evaluations of Rotavirus Vaccine in Low- and Middle-Income Countries and a Proposed Assessment Framework.The French National Authority for Health (HAS) Guidelines for Conducting Budget Impact Analyses (BIA).The use of budget impact analysis in the economic evaluation of new medicines in Australia, England, France and the United States: relationship to cost-effectiveness analysis and methodological challenges.Calculation of prevalence with Markov models: budget impact analysis of thrombolysis for stroke.
P2860
Q30670881-2503B129-791B-45AE-AD95-911570AE423DQ33392179-4C4E65DA-3AEF-4DA0-A631-7E64D18B389AQ34256272-86E48F59-AD96-4A97-B120-5126E625D0D7Q36322923-1ED515F6-B578-47A4-BCF2-963907F8F0A0Q36638320-E46C6ADF-CA6F-4E31-84DF-318B27C4DECEQ36711336-CD09474E-A2AA-4B2E-BF06-E5A6BDAA7417Q37363378-24243721-1DF6-4E35-98CB-23B4C90E2A2BQ37478401-EAE97FCA-3E87-4117-B6AA-DAF92348D361Q37608234-B28F37AB-9AD1-411F-AF7D-81B8FF2AA047Q38155481-CD788A66-392A-4D70-9DCE-1B21E81D4CA4Q38873634-34C89ACA-5F53-44DF-AC50-F599417FD252Q40041895-C02E29AA-F8DB-46C0-BF22-1530B4FC2FFDQ47299182-23BCC7BC-27BC-4CC8-9E08-58501524297DQ50070026-24D2F37A-0FA3-4093-9CF5-66A51933F230Q51114922-825E8039-AE1A-4A8F-8FF5-5B0E7E3EB6E8
P2860
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Prevalence-based economic evaluation.
@en
Prevalence-based economic evaluation.
@nl
type
label
Prevalence-based economic evaluation.
@en
Prevalence-based economic evaluation.
@nl
prefLabel
Prevalence-based economic evaluation.
@en
Prevalence-based economic evaluation.
@nl
P1433
P1476
Prevalence-based economic evaluation.
@en
P2093
Mauskopf J
P304
P356
10.1046/J.1524-4733.1998.140251.X
P577
1998-11-01T00:00:00Z